Silvercrest Asset Management’s Transmedics TMDX Stock Holding History

Silvercrest Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-72,405	Closed	-$5.48M	–	846
2023 Q1	$5.48M	Sell	72,405 -16,337	-18%	-$1.13M	0.04%	330
2022 Q4	$5.48M	Sell	88,742 -46,551	-34%	-$2.47M	0.04%	332
2022 Q3	$5.65M	Sell	135,293 -3,666	-3%	-$159K	0.05%	309
2022 Q2	$4.37M	Sell	138,959 -129,794	-48%	-$3.46M	0.03%	364
2022 Q1	$7.24M	Buy	268,753 +2,522	+0.9%	+$45.2K	0.05%	309
2021 Q4	$5.1M	Buy	266,231 +60,507	+29%	+$1.52M	0.03%	373
2021 Q3	$6.81M	Buy	+205,724	New	+$6.29M	0.05%	332

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Silvercrest Asset Management's TMDX Position: Q2 2023 in Review

Silvercrest Asset Management sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 72,405 shares — an estimated $5.48M sold.

Silvercrest Asset Management first reported a position in TMDX in Q3 2021 and held it in 7 quarters. The position peaked at $7.24M in Q1 2022. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

Silvercrest Asset Management reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
Silvercrest Asset Management sold 72,405 Transmedics shares in Q2 2023, an estimated $5.48M.
Silvercrest Asset Management first reported a position in Transmedics in Q3 2021 and held it in 7 quarters.
Silvercrest Asset Management's Transmedics position peaked at $7.24M in Q1 2022.
240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on Silvercrest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.